Affimed N.V.
AFMD · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $48,573 | $77,132 | $89,398 | $84,476 |
| - Cash | $7,405 | $10,764 | $14,348 | $38,529 |
| + Debt | $12,889 | $14,515 | $16,071 | $19,351 |
| Enterprise Value | $54,057 | $80,883 | $91,121 | $65,298 |
| Revenue | $155 | $154 | $155 | $413 |
| % Growth | 0.6% | -0.6% | -62.5% | – |
| Gross Profit | $155 | $154 | $155 | $413 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$14,446 | -$14,702 | -$16,722 | -$19,317 |
| % Margin | -9,320% | -9,546.8% | -10,788.4% | -4,677.2% |
| Net Income | -$15,139 | -$15,451 | -$19,175 | -$20,205 |
| % Margin | -9,767.1% | -10,033.1% | -12,371% | -4,892.3% |
| EPS Diluted | -0.94 | -1.01 | -1.27 | -1.35 |
| % Growth | 6.9% | 20.5% | 5.9% | – |
| Operating Cash Flow | -$11,135 | -$16,509 | -$23,818 | -$25,442 |
| Capital Expenditures | -$5 | -$19 | -$1 | -$509 |
| Free Cash Flow | -$11,140 | -$16,528 | -$23,819 | -$25,951 |